GUK1 is a target for a number of cancer chemotherapeutic agents [21]; however among the 528 TCGA samples, while deletions of GUK1 was lethal in 93% of the normal controls, it was not lethal in 71% of the lung cancers. The gene discussed is GUK1; the disease is lung carcinoma.